[SCHEDULE 13G] ADMA Biologics, Inc. SEC Filing

Rhea-AI Filing Summary

State Street Corporation reported beneficial ownership of 12,078,505 shares of ADMA Biologics common stock, equal to 5.1% of the outstanding class. The filing discloses shared voting power over 11,187,440 shares and shared dispositive power over 12,078,505 shares, while reporting no sole voting or sole dispositive power. The holder states the position is maintained in the ordinary course of business and not held to influence control of the issuer. Several State Street affiliates are identified as the acquiring subsidiaries and are classified as investment advisers.

Positive

• Aggregate ownership of 12,078,505 shares, representing a material 5.1% stake disclosed in ADMA Biologics
• Shared voting power of 11,187,440 and shared dispositive power equal to the aggregate stake, clarifying control structure
• Filing certifies holdings are in the ordinary course of business and not held to influence control, indicating a passive position

Negative

• The reporting party indicates no sole voting or dispositive power (0 shares), so there is no unilateral control
• Ownership is presented as shared across affiliates, which can obscure which entity exercises specific decision rights

Insights

Financial Analyst

TL;DR State Street holds a material, passive 5.1% stake with shared voting and dispositive power; position not for control.

The Schedule 13G reports a 12,078,505-share position in ADMA Biologics representing 5.1% of the class. Shared voting power is 11,187,440 shares and shared dispositive power equals the aggregate 12,078,505 shares, with zero sole voting or dispositive power. The filing includes the required certification that the stake is held in the ordinary course of business and not to influence control, which characterizes this as a passive, disclosed institutional position rather than an activist or control-seeking holding. This makes the disclosure material from an ownership-transparency perspective but neutral on governance change risk.

Corporate Governance Expert

TL;DR Significant passive ownership disclosed; no sole control rights and affiliates are listed as investment advisers.

The filing names multiple State Street affiliates as the entities through which the securities are held and classifies those affiliates as investment advisers. With no sole voting or dispositive power reported, the registrant signals the absence of unilateral control. For governance analysis, this is an important ownership disclosure but does not indicate a change in board control or proxy dynamics based solely on the reported figures.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ADMA BIOLOGICS INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

000899104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 000899104

1

Names of Reporting Persons

STATE STREET CORPORATION

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MASSACHUSETTS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 11,187,440.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 12,078,505.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

12,078,505.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ADMA BIOLOGICS INC
(b)	Address of issuer's principal executive offices: 465 ROUTE 17 SOUTH , RAMSEY, NEW JERSEY, 7446
Item 2.
(a)	Name of person filing: STATE STREET CORPORATION;
(b)	Address or principal business office or, if none, residence: ONE CONGRESS STREET, SUITE 1, BOSTON MA 02114, UNITED STATES
(c)	Citizenship: MA
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 000899104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 12078505.00
(b)	Percent of class: 5.1 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 11,187,440
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 12,078,505
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. NOT APPLICABLE
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. SSGA FUNDS MANAGEMENT, INC. (IA);STATE STREET GLOBAL ADVISORS EUROPE LIMITED (IA);STATE STREET GLOBAL ADVISORS LIMITED (IA);STATE STREET GLOBAL ADVISORS TRUST COMPANY (IA);STATE STREET GLOBAL ADVISORS, AUSTRALIA, LIMITED (IA);STATE STREET GLOBAL ADVISORS, LTD. (IA);
Item 8.	Identification and Classification of Members of the Group.
	If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group. NOT APPLICABLE
Item 9.	Notice of Dissolution of Group.
	Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. NOT APPLICABLE

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

STATE STREET CORPORATION

Signature:	ELIZABETH SCHAEFER
Name/Title:	SENIOR VICE PRESIDENT, CHIEF ACCOUNTING OFFICER
Date:	08/08/2025

FAQ

How many ADMA (ADMA) shares does State Street report owning?

State Street reports beneficial ownership of 12,078,505 shares of ADMA Biologics common stock.

What percentage of ADMA does State Street own according to the filing?

The reported position represents 5.1% of ADMA Biologics' outstanding common stock.

Does State Street have sole voting control over its ADMA shares?

No. The filing reports 0 shares of sole voting power and 11,187,440 shares of shared voting power.

Is the State Street position in ADMA intended to influence control?

The filing certifies the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.

Which State Street affiliates are identified as holding or acquiring the securities?

Identified affiliates include SSGA Funds Management, Inc., State Street Global Advisors Europe Limited, State Street Global Advisors Limited, State Street Global Advisors Trust Company, State Street Global Advisors, Australia, Limited, and State Street Global Advisors, Ltd. (each classified as investment advisers).